FBXO36: A Potential Drug Target Or Biomarker (G130888)

Target Name: FBXO36

NCBI ID: G130888

FBXO36

Other Name(s): FBX36_HUMAN | Fbx36 | F-box only protein 36 | F-box protein 36

FBXO36: A Potential Drug Target Or Biomarker

FBXO36 (FBX36_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and blood vessels. It is a member of the family of transmembrane proteins, which means that it spans the cell membrane and extends into the cytoplasm. FBXO36 is also known as FBX36 and has been shown to play a role in various cellular processes, including cell signaling, inflammation, and stress response.

One of the unique aspects of FBXO36 is its ability to interact with other proteins and molecules. This interactivity has led to its potential as a drug target or biomarker. FBXO36 has been shown to interact with a variety of proteins, including the protein known as PDGF -BB. This interaction suggests that FBXO36 may be a useful target for drugs that are designed to intervene in the regulation of cell signaling pathways.

In addition to its potential as a drug target, FBXO36 has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that FBXO36 is elevated in the blood vessels of individuals with heart disease. This increase in FBXO36 levels may indicate the presence of underlying cardiac pathology, such as heart failure or ischemia.

FBXO36 has also been shown to be involved in the regulation of cellular stress responses. During times of stress, cells are often activated to produce a variety of signaling molecules in order to adapt to the demands of the body. in the regulation of these stress responses, which may make it an attractive target for drugs that are designed to alleviate the effects of stress in cells.

Another potential application of FBXO36 is its role in the regulation of cell signaling pathways. FBXO36 has been shown to interact with a variety of signaling proteins, including the protein known as FAK. This interaction suggests that FBXO36 may be a useful target for drugs that are designed to inhibit the activity of FAK, which is a protein that is involved in cell signaling.

In conclusion, FBXO36 is a protein that has been shown to play a variety of roles in various cellular processes. Its ability to interact with other proteins and molecules makes it a potential drug target or biomarker. Furthermore, its role in the regulation of cell signaling pathways and stress responses make it an attractive target for drugs that are designed to alleviate the effects of stress in cells. Further research is needed to fully understand the potential applications of FBXO36 as a drug target or biomarker.

Protein Name: F-box Protein 36

Functions: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex

The "FBXO36 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FBXO36 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets